Mergers & Acquisitions
Dental implant, device firm acquired by orthopedics company
Published in Medical Devices and Surgical Technology Week, June 27th, 2004
Under the terms of the agreement, Encore will acquire all of the outstanding common stock of BioHorizons for $5.2 million in cash and approximately 2.6 million shares of Encore common stock, representing a total current acquisition value of approximately $26 million. As a result, the current shareholders of BioHorizons will own approximately 6% of the outstanding stock of Encore after the transaction. There are also up to $10...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Brain Cancer
Microspheres developed for 5-FU delivery to brain - Breast Cancer
RT-PCR for mammaglobin genes detects sentinel lymph nodes micrometastases - Drug Delivery
Chitosan membrane shows promise for transdermal dosing - Liver Cancer
Novel PCR-array system useful for gene expression profiling - Periodontal Disease
TaqMan PCR assay detects six species of periodontopathic bacteria - Acute Coronary Syndrome
FDA clears new intended uses for Troponin T test - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
